AI-generated summary
The authors studied 16 patients with Parkinson's disease who used a head-mounted bright light device or a placebo for one month each in a double-blind crossover design. They report no significant changes in anxiety, fatigue or depression scores, and only a non-significant drop in sleepiness overall. A post hoc analysis of patients with high baseline sleepiness found a significantly greater decrease after bright light therapy.
- Participants
- 16
- Who or what was studied
- Patients with Parkinson's disease
- Limits stated in the abstract
- The sleepiness finding comes from a post hoc subgroup analysis in a small sample of 16 patients.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Anxiety, Depression, Bright light therapy, Placebo-controlled, Primary outcome. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.